BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Omeros Corporation Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824

  November 1, 2012

   · 

  3 min read
• Business

  Michael Lehmann Appointed Patheon Inc.'s President of Global Pharmaceutical Development Services

  November 1, 2012

   · 

  2 min read
• Drug Development

  Isis Pharmaceuticals, Inc. Initiates Phase 1b/2a Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy

  November 1, 2012

   · 

  6 min read
• Biotech Beach

  Ligand Pharmaceuticals Inc. to Host Analyst Day on December 4th in New York City

  November 1, 2012

   · 

  1 min read
• Business

  Navidea BiopharmaceuticalsThird Quarter 2012 Earnings and Business Update Conference Call Invitation

  November 1, 2012

   · 

  1 min read
• Business

  BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President

  November 1, 2012

   · 

  1 min read
• Business

  Teva Pharmaceutical Industries Limited Reports Third Quarter 2012 Results

  November 1, 2012

   · 

  1 min read
• Biotech Bay

  Affymetrix (Santa Clara, California) Introduces Axiom® Biobank Arrays for Genotyping Studies

  November 1, 2012

   · 

  1 min read
• Business

  ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)

  November 1, 2012

   · 

  1 min read
• Drug Development

  FibroGen, Inc. to Present Phase 2 Data for FG-4592, An Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), at American Society of Nephrology Kidney Week 2012

  November 1, 2012

   · 

  1 min read